Valuation: ResMed, Inc.

Market Cap 2.78TCr 2.44TCr 2.26TCr 2.08TCr 3.92TCr 2,68500Cr 3.98TCr 27TCr 11TCr 1,31400Cr 10TCr 10TCr 4,53900Cr P/E 2026 *
18.2x
P/E 2027 * 17.1x
Enterprise Value 2.7TCr 2.37TCr 2.2TCr 2.02TCr 3.8TCr 2,60500Cr 3.86TCr 26TCr 10TCr 1,27500Cr 10TCr 9.92TCr 4,40400Cr EV / Sales 2026 *
4.78x
EV / Sales 2027 * 4.39x
Free-Float
75.61%
Yield 2026 *
1.26%
Yield 2027 * 1.36%
1 day-1.48%
1 week-2.85%
Current month-1.01%
1 month+2.37%
3 months-13.12%
6 months-24.45%
Current year-19.91%
1 week 191.67
Extreme 191.67
203.04
1 month 190.25
Extreme 190.25
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-2.85%-27.86%-12.29% 2.78TCr
+0.57%-1.65%+23.11%-6.36% 20TCr
+0.07%-10.78%-5.67%-29.99% 13TCr
-2.68%-12.41%-33.33%+1.20% 12TCr
-0.51%-0.16%-58.35%-19.17% 6.39TCr
-0.21%-3.32%+10.58%-8.86% 4.86TCr
+0.17%-0.52%-24.32%-32.66% 4.39TCr
+0.45%-0.93%+14.86%+4.58% 3.77TCr
+0.89%-1.09%+29.00%+28.44% 3.64TCr
-0.86%+1.99%+87.07%+0.20% 2.89TCr
Average -0.07%-2.90%+1.51%-7.49% 7.29TCr
Weighted average by Cap. +0.14%-4.74%-1.55%-9.73%

Financials

2026 *2027 *
Net sales 564.98Cr 495.04Cr 459.57Cr 422.3Cr 795.76Cr 55TCr 807.47Cr 5.47TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr 596.05Cr 522.26Cr 484.84Cr 445.52Cr 839.52Cr 58TCr 851.87Cr 5.78TCr 2.26TCr 28TCr 2.24TCr 2.19TCr 97TCr
Net income 154.52Cr 135.39Cr 125.69Cr 115.5Cr 217.63Cr 15TCr 220.84Cr 1.5TCr 586.04Cr 7.3TCr 580.04Cr 567.54Cr 25TCr 160.57Cr 140.69Cr 130.61Cr 120.02Cr 226.16Cr 15TCr 229.49Cr 1.56TCr 609.01Cr 7.58TCr 602.78Cr 589.79Cr 26TCr
Net Debt -83Cr -72Cr -67Cr -62Cr -116.43Cr -7.98TCr -118.14Cr -801.04Cr -313.52Cr -3.9TCr -310.31Cr -303.63Cr -13TCr -164.65Cr -144.27Cr -133.93Cr -123.07Cr -231.91Cr -16TCr -235.32Cr -1.6TCr -624.48Cr -7.77TCr -618.09Cr -604.77Cr -27TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
22/26/22 $192.91 -1.48% 9,71,174
21/26/21 $195.80 -1.41% 11,12,740
20/26/20 $198.61 -0.19% 10,37,424
17/26/17 $198.99 -1.86% 12,84,198
16/26/16 $202.76 +2.11% 10,19,540
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
192.91USD
Average target price
247.93USD
Spread / Average Target
+28.52%

Quarterly revenue - Rate of surprise